Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech World Equatorial Guinea.
Press releases published on June 25, 2025

Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update
Sanofi to advance Kymera’s next-generation oral IRAK4 degrader development candidate, KT-485, into clinical testing and will not advance KT-474 In preclinical testing, KT-485 demonstrated increased selectivity and potency with a favorable safety profile …

Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
DOVER, Del., June 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”), announced today that on June 24, 2025 …

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
WARREN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …

Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan
PRINCETON, N.J., and TOKYO, June 25, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) for the …

Wowza Acquires AVA Intellect as it Accelerates Commitment to AI-First Innovation Strategy
Acquisition aligned with Wowza’s vision for intelligent video infrastructure, bringing agent-based automation to streaming orchestration and optimization. Wowza appoints AVA Intellect co-founder Mike Vitale as Head of Intelligence at Wowza. DENVER, June 25 …

Coin Casino Launches Instant Crypto Withdrawal System with No ID Verification for U.S. Players
SAN JUAN, Puerto Rico, June 25, 2025 (GLOBE NEWSWIRE) -- Coin Casino, a licensed crypto gaming platform, today announced the rollout of its Instant Crypto Withdrawal System, a major update that allows registered players to cash out winnings instantly and …

New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents
ALAMEDA, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced the global expansion of its partner program and new Jitterbit University partner curricula. …

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve …

Agillic approved as ‘SKI’ vendor for the Danish public sector
Press release – Copenhagen, 25 June 2025 – Agillic A/S Agillic has been approved as a SKI vendor under the framework agreement ’02.06 standard software’, allowing organisations across state, regions, and municipalities to include Agillic’s marketing …

Haal meer uit de cloud met expertise van AWS en een MSP
Amsterdam, Nederland, Juni 2025, Sean Tilley, Director of Sales EMEA bij 11:11 Systems, een provider van beheerde infrastructuuroplossingen, gaat dieper in op de basisinformatie van data voor de moderne onderneming en hoe die bedrijven in staat stelt te …

Transformez le cloud en levier de succès en alliant AWS à l’expertise des MSP
Paris, France, juin 2025, Sean Tilley, directeur commercial senior chez 11:11 Systems, un MSP reconnu, examine le rôle essentiel des données dans l’entreprise moderne et leur importance pour son fonctionnement. Alors que la complexité et la richesse de l’ …

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC …

Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy
Two-part clinical study programme to evaluate change in lean and fat mass in patients receiving two different doses of S-pindolol benzoate whilst 1) receiving the GLP-1 agonist semaglutide; and 2) after cessation of semaglutide treatment Initial proof-of- …

OSE Immunotherapeutics provides an update on ongoing proceedings
OSE Immunotherapeutics provides an update on ongoing proceedings Nantes, June 25th, 2025, 8:00 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces that, following the hearing on June 24th, 2025, regarding the request to retract the …

OSE Immunotherapeutics met à jour l’information sur les procédures en cours
OSE Immunotherapeutics met à jour l’information sur les procédures en cours NANTES, France, 25 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) annonce qu’à la suite de l’audience le mardi 24 juin 2025, relative à la demande …

New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents
FRANKFURT, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced the global expansion of its partner program and new Jitterbit University partner curricula. …

NextBillion.ai selects TomTom Orbis Maps to deliver enhanced enterprise-grade solutions globally
AMSTERDAM, June 25, 2025 (GLOBE NEWSWIRE) -- TomTom (TOM2), the location technology specialist, and NextBillion.ai, a leading provider of AI-powered mapping solutions for enterprise, today announced an expanded partnership to deliver precise route …

Addex Shareholders Approve All Resolutions at Annual General Meeting
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today …

Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney …

Communiqué de presse : Le riliprubart est désigné comme médicament orphelin aux États-Unis pour le rejet induit par les anticorps dans la transplantation d’organes solides
Le riliprubart est désigné comme médicament orphelin aux États-Unis pour le rejet induit par les anticorps dans la transplantation d’organes solides Étude de phase 2 en cours évaluant le riliprubart pour la prévention et le traitement potentiels du rejet …